Dallas children's hospital relocates patients after finding mold

Children's Medical Center Dallas relocated 28 patients after routine air tests


Children's Medical Center Dallas recently relocated 28 patients after routine air tests showed higher-than-normal levels of Aspergillus and Penicillium molds, according to an article on the CNN website.

The patients were moved from the cardiac intensive care unit at Children's Medical Center Dallas to other parts of the facility.

No patients have become infected and none have experienced any health effects as a result of the mold, the hospital said.

No previous tests at the hospital showed mold outside the expected ranges, according to a spokesperson. There is an ongoing investigation into last week's test results.

Read the article.



December 17, 2019


Topic Area: Infection Control


Recent Posts

Barriers to Infection: Rethinking Mattress Cleaning

Laundering removable bed barriers provides a more effective, consistent and safer method for eliminating harmful bacteria compared to manual cleaning.


Over 1 Million Individuals Affected in Community Health Center Data Breach

No evidence of data misuse has been found so far.


Prospect Medical Holdings to Sell Crozer Health to Non-Profit Consortium

The sale includes Crozer Health’s operating assets, including all hospitals, ambulatory surgery centers, clinics and physician offices.


The Top States for Pest Infestations

Healthcare facilities are among the most popular locations for pest infestations.


Ground Broken on Wichita Biomedical Campus Project

The $172.5-million, eight-story, 350,000-square-foot building will be completed in 2026.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.